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INTRODUCTION
An air-bone gap (ABG) is defined as the difference between air-conduction and bone-conduction audiometric thresholds. ABGs 
are found in patients with conductive (CHL) or mixed (MHL) hearing loss generally attributed to outer- and/or middle-ear diseases 
such as otitis externa, tympanic membrane perforation, interruption or fixation of the ossicular chain, and chronic suppurative otitis 
media.
Air-bone gap can also follow the onset of inner-ear structural anomalies, such as enlarged vestibular aqueduct (EVA) syndrome, 
semicircular canal dehiscence, gusher syndrome, cochlear dehiscence, and Paget’s disease [1]. These conditions are mainly charac-
terized by sensorineural hearing loss (SNHL) [2, 3]; however, an ABG can also be found due to the so-called “third-window” mechanism 
[4], where the depletion of acoustic energy from the inner-ear into the middle-ear and/or the cranial cavity [4, 5] decreases the amount 
of energy delivered to the round window through a third-window. This mechanism provokes a decrease in the pressure gradient 
across the basilar membrane, leading to a decreased perception of air-conducted sound that progresses to a low-frequency ABG 
[5]. ABGs have additionally been reported in patients with endolymphatic hydrops (EH); in this context, an ABG can be explained 
by increased perilymphatic pressure with a consequent decrease in stapes mobility or by saccular dilation leading to a reduc-
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Air–bone gaps (ABGs) are commonly found in patients with conductive or mixed hearing loss generally due to outer- and/or middle-ear diseases 
such as otitis externa, tympanic membrane perforation, interruption or fixation of the ossicular chain, and chronic suppurative otitis media. ABGs 
can also be found in correlation with inner-ear disorders, such as endolymphatic hydrops, enlarged vestibular aqueduct syndrome, semicircular 
canal dehiscence, gusher syndrome, cochlear dehiscence, and Paget disease’s as well cerebral vascular anomalies including dural arteriovenous 
fistula. The typical clinical presentation of inner-ear conditions or cerebral vascular anomalies causing ABGs includes audiological and vestibular 
symptoms like vertigo, oscillopsia, dizziness, imbalance, spinning sensation, pulsatile or continuous tinnitus, hyperacusis, autophony, auricular 
fullness, Tullio’s phenomenon, and Hennebert’s sign. Establishing a definitive diagnosis of the underlying condition in patients presenting with an 
ABG is often challenging to do and, in many patients, the condition may remain undefined. Results from an accurate clinical, audiological, and ves-
tibular evaluation can be suggestive for the underlying condition; however, radiological assessment by computed tomography and/or magnetic 
resonance imaging is mandatory to confirm any diagnostic suspicion. In this review, we describe and discuss the most recent updates available 
regarding the clinical presentation and diagnostic workup of inner-ear conditions that may present together with ABGs.
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tion in stapedial mobility. Cerebral vascular anomalies including du-
ral arteriovenous fistula (DAVF) may also be responsible for an ABG 
due to communication between the inner-ear and the cranial cavity 
through the cochlear and vestibular aqueducts and multiple small 
neurovascular foramina, facilitating contiguity between the perilym-
phatic and subarachnoid spaces [6].
The typical clinical presentation of inner-ear conditions or cerebral 
vascular anomalies causing ABGs includes audiological and vestibu-
lar symptoms like vertigo, oscillopsia, dizziness, imbalance, spinning 
sensation, pulsatile or continuous tinnitus, hyperacusis, autophony, 
auricular fullness, Tullio’s phenomenon, and Hennebert’s sign [7].
Establishing a definitive diagnosis is often challenging and, in many 
patients, the underlying condition remains unknown. This review 
sought to describe and discuss the most recent updates available re-
garding the clinical presentation and diagnostic workup of inner-ear 
conditions that may present together with an ABG.
CLINICAL AND RESEARCH CONSEQUENCES
Superior Semicircular Canal Dehiscence (SSCD)
Superior semicircular canal dehiscence (SSCD) is an idiopathic condi-
tion characterized by a loss of the bony wall of the superior semicir-
cular canal that promotes communication between the semicircular 
canal and the middle cranial fossa. The incidence of SSCD in the gen-
eral population is difficult to estimate; for example, Minor [8] reported 
65 cases in a nine-year period. Some risk factors have been reported 
to correlate with SSCD including direct mechanical trauma, increased 
cerebrospinal fluid pressure, increased pressure following Valsalva 
maneuvers, underdevelopment of bone overlying the semicircular 
canal, and progressive erosion due to vascular pulsations [9].
The clinical presentation of SSCD includes spontaneous or positional 
dizziness, vertigo following pressure or sound, and vertical nystag-
mus [10]. In some cases, SSCD can be asymptomatic, making the estab-
lishment of a clinical diagnosis harder [11].
The typical audiological feature of SSCD is an ABG in the low and 
middle frequencies (≤ 2,000 Hz); bone-conduction thresholds can be 
present at supranormal levels [12], which can facilitate a misdiagnosis 
of CHL. At frequencies of 2000 Hz or higher, only a limited, or ab-
sent gap can be found because less acoustic energy passes through 
the third window. The degree of ABG may be related to the location, 
length, or cross-sectional area of the SSCD [13].
Many techniques have been proposed to diagnose SSCD, including 
audiometry, complete immittance testing with tympanometry and 
acoustic reflexes, and air-conducted vestibular-evoked myogenic po-
tential (VEMP) testing. The diagnostic confirmation of a true case of 
dehiscence should involve a high-resolution computed tomography 
(CT) scan of the temporal bone using multiplanar reconstructions in 
the planes of Stenver and Pöschl; Pöschl views parallel and Stenver 
views perpendicular to the plane of the superior semicircular canal 
have the highest diagnostic specificity [14].
The treatment of SSCD is exclusively surgical and includes capping 
or plugging of the SSCD or reinforcement of the oval and/or round 
windows [15].
Posterior Semicircular Canal Dehiscence (PSCD)
Posterior semicircular canal dehiscence (PSCD) is an uncommon ca-
nal dehiscence [10] that can be observed alone or in combination with 
SSCD with frequencies of 0.3% and 4.5%, respectively [5]. The PSCD 
can extend into the posterior fossa dura through communication 
with a high-riding jugular bulb or via a bony defect. Often, PSCD re-
sults from jugular bulb erosion or fibrous dysplasia [9].
Audiological symptoms associated with PSCD are similar to those in 
SSCD; a clinical suspicion for PSCD should arise if bone-conduction re-
sponses are at 5 dB HL or better, a biphasic complex at VEMP test elicits 
a lowered threshold at an increased amplitude, and vestibular signs 
like nystagmus are present in the plane of the posterior semicircular 
canal. Pure tone audiometry in the half-octave is useful to confirm the 
characteristic low-frequency ABG correlated with this condition [16].
Lateral Semicircular Canal Dehiscence (LSCD)
Lateral semicircular canal dehiscence (LSCD) is often the result of 
middle-ear diseases such as otitis media [17], cholesteatoma, and ca-
nal-wall-down mastoidectomy [9, 18]; isolated LSCD is extremely un-
usual [18] and has been reported only in patients with dysplastic bony 
labyrinths to date. It is very difficult to ascertain whether ABG in LSCD 
is related to abnormalities of the middle-ear or to a third-window 
mechanism of the LSCD [19] (Figure 1).
Patients with LSCD can present with an ABG in the low-frequency 
range. In cases of fistula secondary to cholesteatoma, vertigo and ipsi-
lateral nystagmus may be induced by pressure applied to the external 
auditory canal [20]. In this scenario, it is controversial as to whether the 
matrix of cholesteatoma should be completely removed or whether 
a thin layer should be left in place to prevent possible deafness due 
to labyrinthine exposure [9]. Previously Chen et al. reported on the 
complete surgical removal of cholesteatoma in 22 patients with LSCD; 
two of them experienced postoperative hearing losses of 5 to 15 dB, 
whereas the others presented with stable or improved hearing [21].
Enlarged Vestibular Aqueduct (EVA) Syndrome
The vestibular aqueduct have a diameter, on average, of 0.6 mm [22]. 
If the vestibular aqueduct is dilated to a diameter of greater than 
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• An air-bone gap, typical of conditions that involve the exter-
nal and middle ear, can also be found in conditions affect-
ing the inner-ear due to a third-window mechanism or in 
idiopathic or secondary endolymphatic hydrops
• Typical clinical presentation of inner-ear conditions with air-
bone gaps may include several audiovestibular symptoms 
such as vertigo, oscillopsia, dizziness, imbalance, tinnitus, 
hyperacusis, autophony, auricular fullness, and Tullio’s phe-
nomenon.
• Accurate clinical, audiological, and vestibular evaluations 
can be suggestive of the underlying condition for hearing 
loss presenting with an air-bone gap.
MAIN POINTS
1.5 mm [23], such can give rise to complex and variable auditory and 
vestibular symptoms because it may act as a third-window. EVA is a 
relatively rare condition that often occurs bilaterally alone or in asso-
ciation with various congenital diseases, such as Pendred syndrome, 
choanal atresia, coloboma, heart defects, retarded development, 
and branchio-oto-renal syndrome along with a variety of inner-ear 
anomalies that may be due to the onset of higher inner-ear pressures 
following a third-window mechanism [24] (Figure 2). Fluctuating or 
progressive mixed or sensorineural hearing loss [25] is a typical audio-
metric feature of EVA. In patients with EVA, ABG in the low-frequen-
cy range is provoked by a third-window mechanism that increases 
bone-conduction to near-normal levels [26].
Vestibular symptoms include episodic vertigo and occasional un-
steadiness and dizziness; the former is more typical of adult patients, 
while the latter predominate in children, mimicking other disorders 
such as otosclerosis and Ménière-like disease or semicircular canal 
dehiscence [5].
Vestibular-evoked myogenic potential testing may represent a use-
ful diagnostic test in EVA demonstrating lower thresholds and higher 
amplitudes despite the presence of ABG on the side of the pathology 
[27]. However, the definitive diagnostic technique for EVA is radiolog-
ical in nature, involving CT and magnetic resonance imaging (MRI). 
CT diagnostic criteria are based on the dimension of the vestibular 
aqueduct following the Valvassori [23] or the Cincinnati [28] criteria. 
MRI, especially involving T2-weighted images, is useful to visualize 
the membranous labyrinth and show the extraosseous portion of the 
endolymphatic sac [29].
To date, there is no evidence of a treatment able to limit the progres-
sion of EVA. Significant audiometric benefits have been observed 
in EVA patients receiving a cochlear implant [30, 31], while temporary 
hearing improvements were documented by Grimmer et al. when 
treating EVA patients with corticosteroid therapy [32].
X-Linked Stapes Gusher
Stapes gusher syndrome is a congenital disorder linked to a mutation 
in the POU3F4 gene on the X chromosome affecting almost exclu-
sively males. Female carriers can be asymptomatic or present a less 
severe degree of hearing loss, depending on the type of mutation [33]. 
Clinical features include congenital mixed hearing loss that worsens 
to severe deafness within eight to 10 years due to perilymphatic hy-
drops [33]. ABG is typically found in the low-frequency range, reflecting 
a third-window mechanism due to the absence of the lamina cribro-
sa and consequent communication between the perilymphatic and 
subarachnoid spaces; while the stapedial reflex may be preserved [4].
Computed tomography imaging can reveal abnormalities like co-
chlear hypoplasia, an enlarged internal auditory canal, absent modi-
olus and lamina cribrosa, and a labyrinthine facial nerve canal with a 
classic corkscrew appearance of the cochlea [34]. Cochlear implanta-
tion is indicated in patients with severe or profound SNHL, although 
careful insertion of the electrode is mandatory. Stapes surgery 
should be avoided due to the high risk of cerebrospinal fluid leak and 
meningitis; outcomes are not encouraging relative to those of other 
inner-ear abnormalities [35].
Bone Dyscrasias
Bone dyscrasias include a number of metabolic bone diseases such 
as Paget’s disease and osteogenesis imperfecta that show a patho-
logic bone turnover with involvement of the otic capsule. These con-
ditions incite osteoclastic activation, inducing a third-window effect 
with a consequent low-frequency ABG at pure tone audiometry [36].
Osteogenesis imperfecta is caused by mutations in type I collagen 
synthesis, producing brittle bones and lax joints and ligaments as 
a result of existing fragile connective tissue [24]. Afflicted patients 
present with skeletal abnormalities and fractures due often to mild 
traumas; otic capsule mineralization can be facilitated with the use 
of bisphosphonates and dietary supplements [37]. Surgical options—
which are, unfortunately, characterized by poor outcomes—include 
stapes surgery for fenestral disease [38] and cochlear implantation for 
retrofenestral disease.
Paget’s disease is characterized by a dystrophic remodeling of bone 
tissues and consists of an initial phase of bone resorption followed by 
a sclerotic phase and a final remodeling phase with, typically, lamellar 
bone; the bones show a typical mosaic-bone pattern [39]. Patients with 
Paget’s disease experience progressive bilateral hearing loss; Amilib-
ia Cabeza et al. [2] reported that subjects affected by Paget’s disease 
showed a more profound and higher incidence of CHL as compared 
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Figure 1. Computed tomography (CT) scan. Lateral semicircular canal dehis-
cence due to chronic otitis media. The cortical bone of the middle fossa and 
the tegmen tympani are thinner than expected as a result of the erosive phe-
nomena induced by the reactive tissue.
Figure 2. Computed tomography (CT) scan. Presentation of bilateral enlarged 
vestibular aqueducts in a 11-year old child with an history of bilateral con-
ductive hearing loss. The child did not present any sign of middle-ear disease.
with among healthy controls [2]. The pursuit of cochlear implantation 
is suggested in patients with severe and profound hearing loss [40].
Cochlear Dehiscence
Cochlear dehiscence refers to a thinning of the bone plate that cov-
ers the cochlea, which results in the establishment of direct com-
munication between the inner-ear and the middle-ear cavity or 
neurovascular structure. When the scala vestibuli of the cochlea is 
compromised, a third-window mechanism occurs, decreasing co-
chlear input impedance and reducing the pressure within the scala 
vestibuli produced by sound [4]. Kim and Wilson [41] described the case 
of a dehiscence between the cochlea and carotid canal with an ABG 
that persisted after uneventful stapedectomy, while Fang reported 
a dehiscence that involved the geniculate ganglion, labyrinthine, or 
tympanic segments of the facial nerve [42].
Endolymphatic Hydrops (EH)
Endolymphatic hydrops (EH) is an idiopathic condition characterized 
by the enlargement of endolymphatic volumes in the inner ear with 
distension of Reissner’s membrane into the scala vestibuli of the co-
chlea and/or the saccule, utricle, and ampullae of the semicircular 
canals. EH is the pathogenic mechanism that underlies Ménière’s dis-
ease, a disorder of the inner-ear characterized by fluctuating hearing 
loss, vertigo attacks, tinnitus, and aural fullness [43].
EH typically results in SNHL; however, low-frequency ABGs can also 
be found in the absence of middle-ear pathology [44]. An ABG in EH 
can be explained by the onset of increased perilymphatic pressure 
with a consequent decrease of stapes mobility or by saccular dilation, 
leading to a reduction in stapedial mobility as found by Okuno and 
Sando in the temporal bones of patients with Ménière’s disease [45].
Recently, 3-tesla MRI has been used to evaluate for the presence of EH 
[44], revealing a direct relationship between vertigo attacks and low-fre-
quency ABGs due to a worsening of EH. Sugimoto et al. [46] noted that 
the average bone-conduction thresholds in patients with EH were 
higher in those with EH adjacent to the stapes footplate, with more 
frequent ABGs at 250 Hz. Moreover, these authors found that patients 
with significant cochlear and vestibular EH adjacent to the stapes foot-
plate had more frequent and longer Ménière’s disease crises relative 
to those with EH nonadjacent to the stapes footplate. Elsewhere, Ma-
heu et al. [47] found that the mean ABG frequency is clinically higher in 
patients with Ménière’s disease than in EH patients, without noticing 
a significant correlation between the mean ABG frequency and the 
summating potential (SP)/action potential (AP) area or amplitude ratio. 
However, Bess et al. [1] reported three cases of unexplained CHL sug-
gesting that the cause of secondary EH and subsequent ABGs in these 
cases could be an anomaly of the inner-ear fluids.
In 1965, Godlowski [48] first described the causative relation between 
altered venous drainage of the vestibular and/or the cochlear veins 
into the venous cerebrospinal system and secondary EH. Cassandro 
et al. [49] presented a case of dural arteriovenous fistulas (DAVF) in a 
55-year-old female patient with unilateral left ear pulsatile tinnitus 
and CHL, supposing that type II DAVF provokes subclinical intracrani-
al hypertension with a prolonged parenchymal phase of the venous 
outflow. This mechanism could be responsible for a disturbance in 
the stria vascularis circulation, resulting in pulsatile tinnitus, and CHL. 
To our knowledge, only one case of hearing loss associated with 
DAVF has been reported in the literature; however, the hearing loss 
was sensorineural [50]. An alteration in the venous cerebral circulation 
can indicate otologic symptoms like pulsatile tinnitus as a result of 
labyrinth hydromechanics in conditions such as bilateral transverse 
sinus stenosis or DAVF [50]. In these conditions, there is a communica-
tion between intracranial fluids and the cochlear aqueduct.
Clinical Investigations
The typical conditions presenting with an ABG are pathologies af-
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Diagnostic measures Middle ear involvement Third-window lesion  Endolymphatic hydrops conditions
Type of hearing loss Conductive hearing loss Conductive or mixed hearing loss Generally mixed or sensorineural hearing loss
Air-bone gap 0–60 dB, may involve all frequencies 0–60 dB, greatest at frequencies <2000 Hz 0–50 dB, greatest at frequencies <1000 Hz 
Bone conduction  Rarely < 0 dB  Sometimes negative (−5 to −25 dB  Rarely < 0 dB 
thresholds    for low frequencies
Tympanometry Type A or B or C tympanogram  Type A tympanogram  Type A tympanogram 
Acoustic reflex Absent Present Generally present 
Tullio phenomenon  Absent  May be present Absent 
and/or Hennebert sign 
Otoacoustic emissions Absent  May be present Generally absent 
ECochG Normal Generally elevated SP/AP ratio SP/AP ratio generally > 0.37 
Cervical VEMP Absent Low threshold and large amplitude Generally absent or lower peak-to-peak  
   amplitude at 500 Hz that 1000 Hz  
   (tuning shift)
CT/MRI scan Middle ear abnormality  Third-window lesion Distension of the structures filled with  
   endolymph at MRI
ECochG: Electrocochleography; VEMP: vestibular evoked myogenic potentials; CT: computed tomography; MRI: magnetic resonance imaging; SP: Summating 
Potentials, AP: Action Potentials.
Table 1. Diagnostic strategy to differentiate middle-ear involvement, third-window lesions, and endolymphatic hydrops conditions
fecting the outer or middle ear. Therefore, the completion of accurate 
otoscopic, nasal, and rhinopharingeal examinations is mandatory to 
assess the external auditory canal, tympanic membrane, and per-
itubal areas, followed by complete immittance testing. Details about 
the diagnostic strategy to differentiate middle-ear involvement, 
third-window lesions, and EH conditions are suggested in Table 1.
Findings of a type A tympanometry curve and normally evoked acous-
tic reflexes in patients presenting with an ABG generally exclude an 
alteration of the middle-ear and should suggest a third-window le-
sion [12]. Cervical VEMP testing and the measurement of otoacoustic 
emissions are also helpful in elucidating the ABG condition, as both 
cervical VEMP and otoacoustic emissions are present in third-win-
dow lesions and absent in patients with middle-ear disease [12, 51]. Fur-
thermore, cervical VEMP can be beneficial in evaluating EH, showing 
a biphasic complex greater in amplitude and lower in threshold for 
1,000 Hz tone-burst stimuli relative to 500-Hz ones (tuning shift) [52]. 
An elevated SP/AP ratio as measured by electrocochleography has 
long been considered the electrophysiological correlate of EH-re-
lated clinical conditions. Similarly, an SP/AP ratio higher than 0.37 is 
considered indicative of EH [52].
Laser Doppler vibrometry can also help in differentiating middle- 
from the inner-ear diseases in patients with ABG when measuring 
umbo velocity [12]. Bedside vestibular examination can be useful to 
evaluate patients affected by third-window lesions given that sound 
stimulation (Tullio phenomenon), tragal compression (Hennebert 
sign), or pressure changes in the external ear canal (Valsalva maneu-
vers) may elicit dizziness and vertical-torsional nystagmus [53].
Imaging of third-window mechanism-based lesions relies on CT and 
MRI. High-resolution CT of the temporal bone is recommended to 
correctly evaluate third-window lesions [24]. CT has a central role in 
identifying semicircular canal dehiscence; MRI is equally sensitive in 
differentiating fluid from bone but should not be used as the pre-
ferred tool in the evaluation of third-window lesions [54]. MRI along-
side magnetic resonance angiography may be useful for assessing 
central vascular abnormalities like DAVF. EH may be evaluated using 
MRI at 24 hours after the intratympanic administration of gadolini-
um-based contrast [54].
CONCLUSION
An ABG is an audiological finding typical of pathologies that involve 
the external or middle-ear; sometimes, an ABG can be found in con-
ditions affecting the inner-ear due to a third-window mechanism or in 
idiopathic or secondary EH conditions such as central vascular abnor-
malities. Although making a definitive diagnosis is often challenging, 
accurate clinical, audiological, and vestibular evaluations can be sug-
gestive of the underlying condition; however, radiological assessments 
by CT and/or MRI are mandatory to confirm any diagnostic suspicion.
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